Related Experiment Video
Updated: Aug 6, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Multimodal evoked potentials in three siblings with mitochondrial disease
Kuan-Lin Lai1, Chih-Yang Liu, Yo-Chuen Liu
1Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan.
Multimodal evoked potential (EP) studies revealed that the A8344G mitochondrial DNA mutation impacts the central nervous system, even without apparent symptoms. EP testing aids in detecting functional disturbances and mapping nervous system involvement in mitochondrial diseases.
Area of Science:
- Neuroscience
- Genetics
- Clinical Medicine
Background:
- Mitochondrial diseases are complex, multi-system disorders with varied presentations.
- The A8344G mutation in mitochondrial DNA is associated with certain neurological manifestations.
- Early detection of nervous system involvement is crucial for managing mitochondrial diseases.
Purpose of the Study:
- To investigate the utility of multimodal evoked potential (EP) studies in assessing central nervous system involvement in siblings with the A8344G mitochondrial DNA mutation.
- To correlate EP findings with clinical symptoms and genetic mutations in mitochondrial disease.
Main Methods:
- Multimodal evoked potential (EP) testing, including visual, motor, somatosensory, and brainstem auditory evoked potentials.
- Genetic analysis to identify the specific A8344G mitochondrial DNA mutation.
- Clinical assessment of neurological symptoms, including diabetes mellitus (DM) and encephalopathy.
Main Results:
- Abnormalities were observed in visual EPs in one patient.
- Motor, somatosensory, and brainstem auditory EPs were abnormal in all three siblings.
- EP findings indicated widespread central nervous system involvement, irrespective of overt clinical symptoms.
Conclusions:
- Evoked potential (EP) studies are valuable adjuncts for detecting functional disturbances in mitochondrial diseases.
- EP testing can effectively screen for the distribution of nervous system involvement in patients with mitochondrial DNA mutations.
- Multimodal EPs provide objective evidence of subclinical neurological deficits associated with mitochondrial DNA mutations.
More Related Videos
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018